about
Global burden of invasive nontyphoidal Salmonella disease, 2010(1)Antimicrobial resistance and management of invasive Salmonella diseaseA prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, MalawiGenomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian childrenInvasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.Human melioidosis, Malawi, 2011.A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi.A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out.Rapid emergence of multidrug resistant, H58-lineage Salmonella typhi in Blantyre, Malawi.Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in MalawiTyphoid fever and invasive nontyphoid salmonellosis, Malawi and South AfricaThree Epidemics of Invasive Multidrug-Resistant Salmonella Bloodstream Infection in Blantyre, Malawi, 1998-2014.Mathematical Modeling to Assess the Drivers of the Recent Emergence of Typhoid Fever in Blantyre, Malawi.Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa.Characterization of the Prophage Repertoire of African Salmonella Typhimurium ST313 Reveals High Levels of Spontaneous Induction of Novel Phage BTP1.Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosisDistinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings.Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012.Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient.Management of severe non-TB bacterial infection in HIV-infected adults.Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study.Drug resistance in Salmonella enterica ser. Typhimurium bloodstream infection, Malawi.Public health surveillance in the UK revolutionises our understanding of the invasive Salmonella Typhimurium epidemic in Africa.Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosis.Identifying volatile metabolite signatures for the diagnosis of bacterial respiratory tract infection using electronic nose technology: A pilot study.Speciation of common Gram-negative pathogens using a highly multiplexed high resolution melt curve assay.The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management.Erratum: Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings.Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action.Role of a single noncoding nucleotide in the evolution of an epidemic African clade of Salmonella.Functional analysis of Salmonella Typhi adaptation to survival in waterGenomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineagesChloS-HRM, a novel assay to identify chloramphenicol-susceptible Escherichia coli and Klebsiella pneumoniae in MalawiKeep it clean: hospital-acquired infections in childrenTyphoid vaccine development with a human challenge modelTreatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection ModelDomestic River Water Use and Risk of Typhoid Fever: Results From a Case-control Study in Blantyre, MalawiEmergence of carbapenemase-producing Enterobacteriaceae in Malawi
P50
Q26828546-77DC6CC3-6A15-4387-9E18-3EF82A615383Q28080658-3C5E3694-DCA2-407E-A65B-8BEAAE946151Q28534417-3D04D68C-3515-4B00-A301-48EAD5145A90Q33706348-AD76F000-8548-4133-B6B2-CBFB3B9CCF10Q33745704-03080512-94B6-4DB8-AD27-52A43D0FE9E5Q34275116-1FF2C642-1DA1-4557-865B-6DE1A11746B9Q34348592-D8BBA07B-1BAE-496D-B07A-AEB787CFA499Q34465185-D8C03BA6-97F7-4E70-BCD1-A0EB9CFB5573Q35124323-D4872F29-3007-4087-919E-807E91F349A7Q35536157-50353346-A4E5-414B-B874-39118040DBB0Q35626884-C854164A-E732-468B-B562-F989CAE9DB41Q35729737-6ABADBFF-E98C-4E43-832B-E03976DA02EBQ35806526-6F1EF5CD-54C2-4619-919D-B432B970B38AQ36133437-3E3088E7-E966-4B5A-B555-B2BB554A855CQ36133450-1E0DF685-E9B1-478E-86AE-D100B370B619Q36140982-53957520-541C-4FE0-8D73-759D6FD6D91EQ36303585-8E6AB2F1-96BF-47C2-A340-7C9222C14FE3Q36970981-EC039715-40BC-4E6B-9AB5-53F351F94D04Q37305395-EF0A3AF2-527F-4A33-B4AF-37A9A5580B9FQ37726056-C563A329-34EB-4988-AF1C-5D672F00B8C8Q37903384-E0C1C88A-7F9A-46B9-949A-E53F33475786Q38314390-C15171A0-4BD3-4762-BB73-F7B7FB650C6BQ39284005-E630BB85-B33D-45F4-8586-354AAAC3A20FQ42968713-9511EDE8-B4C2-48BF-9828-8471E8F77224Q43102889-3A90DF46-AA82-404B-B12D-40C503739E14Q46531044-F81E8A6C-3610-432C-9AF2-6EC0C122ABD3Q47134751-FB60C773-953E-4385-8C96-05C6ACEF67F2Q49883440-FC5EA0FB-79EE-40A8-BD89-499F6F6FDDB9Q49896091-28E030D7-3FB3-448E-9060-7F06CC83E525Q49953578-C3FEC93F-3F3F-4599-A997-F8BFD2AF44F2Q55078403-29CB06B9-8D99-4658-979B-C1B39579A7DBQ55462159-56C3A581-6445-460C-ADBB-5AFD12814AABQ59796897-5445E0E0-B6A4-4493-81A3-2D4083B92C0AQ62486876-FA9A2AAB-39E2-40B3-AB07-24C6D9548A93Q62487386-4F1CC36D-FFB5-442D-A1D2-798D361A555AQ62494155-EB504A8E-6407-480D-8101-ED2C031EF1B7Q89114032-DF336F30-FD14-4DD9-BD98-EF2CD22CBEF1Q92251974-A1F0688A-75C8-4714-A66E-732FB4231639Q92394787-010B199A-99FF-4F63-8B72-D7C004CAEBD3Q92398543-C49803BB-57E9-4208-8910-9F3ECC757061
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Nicholas A Feasey
@ast
Nicholas A Feasey
@en
Nicholas A Feasey
@es
Nicholas A Feasey
@nl
type
label
Nicholas A Feasey
@ast
Nicholas A Feasey
@en
Nicholas A Feasey
@es
Nicholas A Feasey
@nl
prefLabel
Nicholas A Feasey
@ast
Nicholas A Feasey
@en
Nicholas A Feasey
@es
Nicholas A Feasey
@nl
P31
P496
0000-0003-4041-1405